Understanding unusual hip fractures in people taking bone medications

This study is building a central registry—a detailed database—of patients across Ontario who have experienced an atypical femur fracture, a rare and serious type of hip break that has been associated with long-term use of bisphosphonates (medications commonly used to treat osteoporosis). Researchers want to collect meaningful clinical information from a larger group of patients to better understand what causes these fractures and how they relate to bone-strengthening medications. Right now, what we know about these fractures comes mostly from small case reports or studies of medical records, so detailed patient information is missing.

Atypical femur fractures are debilitating breaks that occur with little or no trauma, yet very little is known about what causes them or how to prevent them. By gathering detailed clinical data from many patients in one place, researchers hope to fill important gaps in understanding the relationship between long-term bone medications and these rare but serious fractures.